drugset
drugset / Trial / NCT03973632

Pharmacokinetic Study of SH-1028 Tablets in Healthy Subjects Under Fasting and Fed Conditions

NCT03973632 ↗

Phase 1 Unknown 16 enrolled Nanjing Sanhome Pharmaceutical, Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the food-effect of SH-1028 Tablets by pharmacokinetics in healthy subjects under fasting and fed conditions.

Timeline

Start
2019-07
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ORITINIB Small molecule 200 mg Oral

Indications

No indication recorded.